CRONOS GROUP INC. Proceeds from Issuance of Secured Debt
CRONOS GROUP INC. (CRON) reported Proceeds from Issuance of Secured Debt of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2021-02-26
- CRONOS GROUP INC. proceeds from issuance of secured debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. proceeds from issuance of secured debt for the quarter ending 2019-03-31 was $316.00K.
- CRONOS GROUP INC. proceeds from issuance of secured debt for fiscal 2020 was $0.00.
- CRONOS GROUP INC. proceeds from issuance of secured debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CRONOS GROUP INC. proceeds from issuance of secured debt for fiscal 2018 was $11.58M, a 130.65% increase from fiscal 2017.
- CRONOS GROUP INC. proceeds from issuance of secured debt for fiscal 2017 was $5.02M.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 12 month |
|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-26 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $0.00 10-K · filed 2021-02-26 | |
| 2019-03-31 | $316.00K 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $11.58M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $5.02M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |